Device aims to decrease wait period for patients needing immunotherapy

Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Centre have created a device that significantly decreases the time needed to produce genetically manipulated T cells in preclinical tests for leukaemia...

Read the whole article on

More from